A5101747360- Respiratory viral infections research
- Traditional Chinese Medicine Analysis
- Medicinal Plant Pharmacodynamics Research
- Influenza Virus Research Studies
- Inflammasome and immune disorders
- Traditional Chinese Medicine Studies
- Respiratory Support and Mechanisms
- Mangiferin and Mango Extracts
- Herpesvirus Infections and Treatments
- Autophagy in Disease and Therapy
- Inflammatory Biomarkers in Disease Prognosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Cervical Cancer and HPV Research
- Veterinary medicine and infectious diseases
- interferon and immune responses
Anhui University of Traditional Chinese Medicine
2011-2023
Abstract Background Pingchuanning decoction is a well‐known traditional Chinese medicine for the treatment of airway inflammatory diseases, including asthma. However, potential mechanism by which contributes to amelioration inflammation remains unknown. Methods A rat model asthma was well established inducing ovalbumin. Lipopolysaccharide‐stimulated tracheal epithelial (RTE) cells were used as cellular model. Lung histopathology and goblet cell hyperplasia assessed hematoxylin‐eosin (HE)...
Shegan Mahuang Decoction has been used in clinical practice for thousands of years, and is a classical formula treating asthma other respiratory diseases, with the effects ventilating lung, dispersing cold, relieving cough asthma. This paper summarized history, application mechanism Decoction, predicted its quality markers(Q-markers) based on "five principles" Q-markers. The results suggested that irisflorentin, tectoridin, tectorigenin, irigenin, ephedrine, pseudoephedrine,...
BACKGROUND Neutrophil-lymphocyte ratio (NLR) is related to increased mortality risk in many diseases. However, there limited research on critically ill patients with chronic obstructive pulmonary disease (COPD). A retrospective cohort study was performed investigate whether NLR can be used as a biomarker predict the of COPD patients. MATERIAL AND METHODS In research, data were gathered from database Medical Information Mart for Intensive Care-IV. The 28-day defined primary outcome, while...